PureHealth Achieves Exceptional Financial Results for FY 2025
PureHealth has delivered outstanding financial performance for the fiscal year ending December 31, 2025. The company reported a notable revenue of USD 7.4 billion, marking a year-on-year increase of 5.7%. The growth reflects the strength and resilience of their Healthcare and Insurance divisions, demonstrating PureHealth's ability to thrive in both local and international markets.
Strong Earnings and Rising Dividends
The growth in revenue was accompanied by an impressive EBITDA of USD 1.3 billion, a 16.1% increase compared to the previous year. The company’s strategic efforts, including operational efficiencies and the recent acquisition of Hellenic Healthcare Group, have driven these noteworthy results.
Financial Highlights
In FY 2025, PureHealth's Net Profit surged to USD 550 million, reflecting a 17.7% increase year-on-year. Additionally, the Group's pretax profits rose to USD 611 million, a robust 26.1% growth. Such financial stability has prompted PureHealth to propose a cash dividend of USD 163 million, representing approximately 30% of their net profit, to be distributed in two equal semi-annual payments.
Dividend Policy and Financial Stability
The proposed dividend is a testament to PureHealth's commitment to delivering shareholder value while ensuring financial flexibility for long-term growth. This strategic dividend policy underscores the Group's solid balance sheet, sustainable cash flow, and disciplined capital allocation.
Global Expansion and Investment Strategy
PureHealth's operations extend beyond its home market, now encompassing regions such as the USA, UK, Greece, and Cyprus. The Group’s diversified portfolio and increasing patient volumes highlight its commitment to enhancing clinical capacity, providing specialized services, and integrating advanced technologies, including AI, to improve healthcare delivery.
Leadership Insights on Growth and Strategy
H.E. Kamal Al Maazmi, Chairman of PureHealth, expressed optimism regarding the Group's evolution into a globally recognized healthcare provider. He remarked, "Our ambition is to establish a technology-enabled healthcare network that fosters resilience and connectivity in patient care. The dividend proposal reflects our confidence in the financial achievements we've secured and our ongoing commitment to sustainable growth that benefits our shareholders."
Farhan Malik, Founder and Managing Director, emphasized the strength of PureHealth's financial performance, stating, "Our continued investment in technology and our strategic acquisitions reinforce our position as a key player in the international healthcare market. With nearly half of our asset base positioned outside the UAE, our business model is increasingly robust and adaptable."
Operational Highlights Across Healthcare Divisions
In the UK, Circle Health has shown remarkable improvement, successfully adjusting its operations to maximize inpatient and outpatient services. In Greece and Cyprus, the contributions from Hellenic Healthcare Group are significant, evidenced by a revenue addition of USD 202 million in Q4 2025, showcasing their growing influence in these markets.
Collaborative Efforts and Innovations
Across the UAE, PureHealth expanded its presence by launching new specialty clinics, enhancing its diagnostic services, and boosting its surgical capabilities. These initiatives have yielded a substantial increase in patient activities, with a noteworthy 15% and 14% growth in outpatient and inpatient volumes, respectively, during FY 2025.
The Cover segment also reported robust growth, with revenue jumping 13.5% year-on-year to USD 2.1 billion, driven by strong customer retention and new enrolments, reflecting the sector's dynamism.
Future Outlook and Expansion Strategy
Looking ahead, PureHealth is poised to amplify its global footprint while reinforcing clinical specialization and digital transformations across its services. The Group aims to target market share expansion in its existing sectors while ensuring operational scalability that enhances profitability.
Internationally, PureHealth’s ambition is clear—transform markets by ensuring that international sectors contribute 50% of the Group's revenue, thus redefining healthcare across various regions.
Frequently Asked Questions
What were PureHealth's total revenues for FY 2025?
PureHealth reported total revenues of USD 7.4 billion for FY 2025, indicating a 5.7% increase year-on-year.
How much is the proposed dividend for shareholders?
The proposed dividend for FY 2025 is USD 163 million, representing around 30% of the company’s net profit.
What factors contributed to PureHealth's profit growth?
The company's profit growth was driven by efficiency improvements, strategic acquisitions, and strong performance in both Healthcare and Insurance segments.
In which countries does PureHealth operate?
PureHealth operates across multiple countries including the UAE, USA, UK, Greece, and Cyprus, enhancing its global presence.
What is PureHealth's strategy for the future?
PureHealth aims to scale its global network, enhance clinical specializations, and leverage AI to improve healthcare delivery across its operations.
